- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.35 Sublease Between the Company and Norian Corporation
- 10.36 Lease Between the Company and Renault & Handley
- 10.37 Amendment to Development, Commercialization and Supply License Agreement
- 12.1 Ratio of Earnings to Fixed Charges
- 21.1 Subsidiaries
- 23.1 Consent of Ernst & Young LLP
- 31.1 302 Certification of CEO
- 31.2 302 Certification of CFO
- 32.1 906 Certification of CEO
- 32.2 906 Certification of CFO
Exhibit 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-108390, 333-98939, 333-86110, 333-47400, 333-61224 and 333-76622) pertaining to the DURECT Corporation 1998 Incentive Stock Plan, the DURECT Corporation 2000 Employee Stock Purchase Plan, the DURECT Corporation 2000 Stock Plan, the DURECT Corporation 2000 Directors’ Stock Option Plan, the Southern BioSystems, Inc. 1993 Stock Option Plan and the Southern Research Technologies, Inc. 1995 Nonqualified Stock Option Plan and in the Registration Statements (Form S-3 Nos. 333-108398 and 333-108396) of DURECT Corporation of our report dated January 30, 2004, with respect to the consolidated financial statements and schedule of DURECT Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2003.
/s/ ERNST & YOUNG LLP
Palo Alto, California
March 9, 2004